345 related articles for article (PubMed ID: 18421213)
1. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
[TBL] [Abstract][Full Text] [Related]
2. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
3. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
[TBL] [Abstract][Full Text] [Related]
4. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
[TBL] [Abstract][Full Text] [Related]
5. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
[TBL] [Abstract][Full Text] [Related]
6. [Predictors of early death during dialysis].
Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
[TBL] [Abstract][Full Text] [Related]
7. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
[TBL] [Abstract][Full Text] [Related]
8. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
[TBL] [Abstract][Full Text] [Related]
9. Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.
Stenvinkel P; Diczfalusy U; Lindholm B; Heimbürger O
Nephrol Dial Transplant; 2004 Apr; 19(4):972-6. PubMed ID: 15031358
[TBL] [Abstract][Full Text] [Related]
10. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Frostegård J
Nephrol Dial Transplant; 2009 Nov; 24(11):3454-60. PubMed ID: 19549697
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
[TBL] [Abstract][Full Text] [Related]
12. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
13. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
[TBL] [Abstract][Full Text] [Related]
14. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM
Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density changes within 11 months of renal transplantation in Iranian patients.
Bayat N; Einollahi B; Pourfarzian V; Alishiri G; Nemati E; Bagheri N; Miri SM; Elizeii PK
Transplant Proc; 2007 May; 39(4):1039-43. PubMed ID: 17524886
[TBL] [Abstract][Full Text] [Related]
17. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients.
Hsu CW; Lin JL; Lin-Tan DT; Yen TH; Chen KH
Ther Apher Dial; 2010 Dec; 14(6):552-9. PubMed ID: 21118362
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
Chiu YL; Chien KL; Lin SL; Chen YM; Tsai TJ; Wu KD
Nephron Clin Pract; 2008; 109(3):c109-18. PubMed ID: 18663322
[TBL] [Abstract][Full Text] [Related]
19. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
[TBL] [Abstract][Full Text] [Related]
20. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
Kalantar-Zadeh K; Kopple JD; Kilpatrick RD; McAllister CJ; Shinaberger CS; Gjertson DW; Greenland S
Am J Kidney Dis; 2005 Sep; 46(3):489-500. PubMed ID: 16129211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]